These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12845675)

  • 1. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma.
    Hirata H; Naito K; Yoshihiro S; Matsuyama H; Suehiro Y; Hinoda Y
    Int J Cancer; 2003 Sep; 106(3):372-4. PubMed ID: 12845675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between matrix metalloproteinase-1 (MMP-1) promoter polymorphism and risk of renal cell carcinoma.
    Piccoli MF; Figueira M; Andreoni C; Marumo JT; Schor N; Bellini MH
    Int Braz J Urol; 2007; 33(5):622-9. PubMed ID: 17980059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
    BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
    Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
    Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
    Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R
    Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population.
    Kouhkan F; Motovali-Bashi M; Hojati Z
    Cancer Invest; 2008 Oct; 26(8):836-42. PubMed ID: 18798060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer.
    Matsumura S; Oue N; Kitadai Y; Chayama K; Yoshida K; Yamaguchi Y; Toge T; Imai K; Nakachi K; Yasui W
    J Cancer Res Clin Oncol; 2004 May; 130(5):259-65. PubMed ID: 14986114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
    Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
    Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
    Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas.
    Nishioka Y; Kobayashi K; Sagae S; Ishioka S; Nishikawa A; Matsushima M; Kanamori Y; Minaguchi T; Nakamura Y; Tokino T; Kudo R
    Jpn J Cancer Res; 2000 Jun; 91(6):612-5. PubMed ID: 10874213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional polymorphism in the matrix metalloproteinase-1 gene promoter is associated with susceptibility and aggressiveness of head and neck cancer.
    O-charoenrat P; Leksrisakul P; Sangruchi S
    Int J Cancer; 2006 May; 118(10):2548-53. PubMed ID: 16353148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population.
    Albayrak S; Cangüven O; Göktaş C; Aydemir H; Köksal V
    Urol Int; 2007; 79(4):312-5. PubMed ID: 18025848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
    de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
    J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness.
    Ghilardi G; Biondi ML; Mangoni J; Leviti S; DeMonti M; Guagnellini E; Scorza R
    Clin Cancer Res; 2001 Aug; 7(8):2344-6. PubMed ID: 11489811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer].
    Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of matrix metalloproteinase-1 promoter genotype on interleukin-1beta-induced matrix metalloproteinase-1 production in human periodontal ligament cells.
    Cao Z; Li C; Xiang J
    J Periodontal Res; 2010 Feb; 45(1):109-15. PubMed ID: 19602108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer.
    Liu L; Wu J; Wu C; Wang Y; Zhong R; Zhang X; Tan W; Nie S; Miao X; Lin D
    Cancer; 2011 Nov; 117(22):5172-81. PubMed ID: 21523769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
    Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
    Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.